Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market

Journals

REMEDIUM

The periodical about the pharmaceutical and medical equipment markets

ROSSIYSKIE APTEKI

(Russian pharmacies) - specialized periodical edition for pgarmacy professionals

MEDITSINSKY SOVET

Medical Council - Scientific Journal for Physicians


Home / News

04.07.2008

Russia's Veropharm Q1 net profit rises 15 pct

Russian drug maker Veropharm said on Thursday its first-quarter net profit rose 15 percent to $6.3 million on the back of higher sales volumes.

Veropharm, part of Russian pharmacy chain 36.6 (APTK.MM: Quote, Profile, Research), said in a statement that revenues, to international financial reporting standards, increased 44 percent to $34.7 million.

Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 30 percent to $9.2 million, but the EBITDA margin declined to 26.4 percent from 29.3 percent.

Gross profit jumped 42 percent to $21.8 million with gross margin coming down to 62.9 percent from 63.8 percent a year ago.

Selling, general and administrative costs soared 51 percent to $13.7 million from $9.1 million in the first quarter of 2007.

At the end of March, Veropharm's debt stood at $17.8 million, accounting for less than 20 percent of its net assets.

Veropharm is one of the largest Russian pharmaceutical producers with a market value of around $550 million.


Source:  www.uk.reuters.com

Remedium group

REMEDIUM

publishing house

CLIFAR

programmer of electronic software products

R-PRESS

advertisement agency

REPRENT

rent-a-rep company